ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,513, issued on Dec. 30, was assigned to ApitBio Inc. (Seoul, South Korea).
"Anti-L1CAM antibodies and uses thereof" was invented by Hyo Jeong Hong (Chuncheon-si, South Korea), Heesu Chae (Seoul, South Korea) and Jisu Hong (Incheon-si, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibodies that specifically bind to L1CAM and compositions comprising such antibodies. Also provided herein are methods for preventing or treating diseases or conditions which comprise a tumor using the anti-L1CAM antibodies."
The patent was filed on Jan. 8, 2024, under Application No. 18/407,065.
*For further information, inc...